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The search for novel bioactive compounds from the natural environment has rapidly
been gaining momentum with the increase in multi-drug resistant (MDR) pathogens.
In the present study, the antimicrobial potential of novel actinomycetes has been
evaluated by initial screening of six soil samples. Primary and secondary screening was
performed against Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Candida
albicans, Candida tropicalis, Trichophyton rubrum, and other MDR bacterial and fungal
test strains, thirteen active isolates were selected for further study. Microbial strains
were identified on the basis of growth conditions and other biochemical characters.
Five most active microbial strains were identified using 16S rRNA sequence homology
and designated as Streptomyces xanthophaeus MTCC 11938, Streptomyces variabilis
MTCC 12266, Streptomyces xanthochromogenes MTCC 11937, Streptomyces levis
EU 124569, and Streptomyces sp. NCIM 5500. Four antibacterial and three antifungal
compounds isolated from the above five isolates were purified and partially characterized
using UV absorption and IR spectra. Two antibacterial metabolites, belong to chromone
and peptide antibiotic, respectively. The antifungal compounds were found to be of
non-polyene nature. In conclusion, we study the isolation of novel bacterial strains
of actinomycetes for producing novel compounds having antibacterial and antifungal
activities from the unexplored agro-ecological niches of India. Also, this study paves the
way for further characterization of these isolates of Streptomyces sp. for their optimum
utilization for antimicrobial purposes.
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INTRODUCTION
The search for bioactive metabolites including novel antibiotic compounds from microbial
sources for potential use in agricultural, pharmaceutical, and industrial applications has
become more important due to the development of drug/multi-drug resistance in most of
the pathogenic microbes. Researchers across the globe are aggressively searching for new,
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potent, sustainable, and broad-spectrum antimicrobial
compounds from various sources including microbes (Berdy,
2005; Hayakawa, 2008; Praveen et al., 2008; Singh and Tripathi,
2011). In natural soil habitat, Streptomyces are usually a major
proportion of the total actinomycetes population and recognized
as prolific producers of useful bioactive compounds (Tanaka and
Omura, 1990; Kekuda et al., 2014).
Traditional screening methods have led to the isolation of
common microorganisms capable of producing metabolites,
which have already been extensively studied and established
(Okami and Hotta, 1988; Kurtböke et al., 1992). Among
the current strategies of natural-product screening, improved
methodologies for isolating the uncommon and less studied rare
actinomycetes are required to avoid the repeated isolation of
the strains that produce known bioactive metabolites, and to
improve the quality of the screened natural products (Takahashi
and Omura, 2003; Berdy, 2005; Singh et al., 2009).
Likewise, the traditional methods of species classification
and the identification of the organism(s) are mainly based on
morphological, physiological, biochemical, developmental, and
nutritional characters, and it is not adequate, and warrants
for the use of molecular level approaches for assigning
accurate taxonomic classification. Hence, precise assignment
of taxonomic status to the novel bioactive microbial isolates
through existing predictive bioinformatics methods and tools are
very essential and aid in chemical characterization of the active
molecules.
India has a unique asset of biodiversity, which can be used as
a treasure for the search of novel isolates. With the variation of
type of soil, according to the geographical changes, soil provide
very complex habitat to the microbes residing in it. Due to
this intricate environment, the soil microbes play an important
role in the isolation of novel drugs. Among soil microbes,
the members of Streptomyces sp. of actinomycetes, have been
widely exploited for the production of commercially important
secondary metabolites and enzymes. In the present study, the
soil samples from six different unexplored agro-ecological niches
of India have been screened-out to isolate Streptomyces sp.
possessing antibacterial and antifungal activities.
MATERIALS AND METHODS
Collection of Soil Samples
The soil samples were collected from six diverse habitats of
India (Lucknow, Uttar Pradesh: 26.7◦N, 80.9◦E; Badrinath,
Uttarakhand: 30.7440◦N, 79.4930◦E; Delhi, New Delhi:
28.6100◦N, 77.2300◦E; Bhatinda, Punjab: 30.2300◦ N, 74.9519◦
E; Haryana: 28.04◦N 76.11◦E; Thinmala range, Kerala: 8.5074◦N,
76.9730◦E) for the isolation of microbes. These habitats included
rhizosphere of the plants, agricultural soil, hospital surroundings,
river mud, and preserved areas of forest soils. The samples were
collected from upto 20 cm depth after the removal of ∼3.0 cm
of the soil from the surface. The soil samples were collected
in polyethylene bags, sealed, and stored in a refrigerator. All
chemicals, media, media components, and other reagents were
purchased from Sigma-Aldrich (USA), Merck (USA), HiMedia
Laboratories (India) etc.
Pre-treatment of Soil Samples and
Isolation of Cultures
The soil samples collected from different geographical areas were
pre-treated to eliminate the commonly found microbes using
physico-chemical methods. For the physico-chemical treatment
of the soil samples, one gram of each soil sample was suspended
in 10 ml of normal saline and distributed in aliquots. One aliquot
of the soil sample was treated with heat for 1 h at 120◦C and
the other was treated with 1.5% phenol for 30 min at 30◦C as
described by Hayakawa et al. (1991). Afterwards, the physico-
chemically treated soil samples were vortexed and left for 30
min, there after soil samples were serially diluted and 100 µl of
each “dilution” was plated on nutrient agar (NA), actinomycetes
isolation agar (AIA), yeast malt glucose agar (M6), antibiotic
assay agar, starch casein agar, and Czapek Dox agar.
Screening of Microbial Cultures
Primary screening for evaluating the antimicrobial potential
of the axenic cultures was performed by perpendicular streak
method of Madigan et al. (1997) against the bacterial strains of
Bacillus subtilis MTCC 441, Staphylococcus aureus MTCC 96,
Escherichia coli MTCC 64, and Candida albicans MTCC 183.
Isolates were screened for antagonism studies by inoculating a
single streak of the pure producer organism in the middle of
the assay media plate. The plates were incubated for 4 days at
28◦C and subsequently seeded with “test” organism by a single
streak at a 90◦ angle to the streak of the “producer strain” and
finally the plates were incubated for 1–2 days at 28◦C. The
microbial interactions were analyzed by determining the distance
of inhibition measured in mm.
Microbial strains showing “moderate” to “good” inhibition
activity were selected for secondary screening, which was
performed by agar well method (Wu, 1984), using 100 µl of their
fermented broth against B. subtilisMTCC 441, B. subtilisMTCC
121, B. pumilus MTCC 1607, S. aureus MTCC 902, S. aureus
MTCC 96, E. coli MTCC 1304, Salmonella typhi MTCC 734,
Pseudomonas aeruginosa MTCC 741, Proteus vulgaris MTCC
426, C. albicansMTCC 3017, C. albicansMTCC 183, C. tropicalis
MTCC 184, Saccharomyces cerevisiae MTCC 170, Cryptococcus
terreusMTCC 1716, Aspergillus nigerMTCC 1344, Trichophyton
rubrum MTCC 296, Penicillium chrysogenum MTCC 2725, and
Beauveria bassiana MTCC 4564. All the experiments were
performed in triplicate and the average values were considered
for analysis.
Characterization of Microbial Strain(s) from
the Selected Cultures
The cultural characteristics of the producer strains were studied
according to the method of Shirling and Gottlieb (1966) based
upon their intensity of growth, growth pattern, colony color
along with the color of aerial and substrate mycelia, and the
formation of soluble pigments on oatmeal agar (ISP-3), inorganic
salt starch agar (ISP-4), glycerol asparagine agar (ISP-5), peptone
yeast extract iron agar (ISP6), and tyrosine agar (ISP-7). The
strains were characterized by streaking the culture(s) on the
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above mentioned medium plates and observed after 7–10 days
of incubation at 28◦C for the given characteristics.
Physiological and biochemical tests were performed as
described by Williams et al. (1989) and Bergey’s manual (Holt
et al., 1994), and results were observed after 10 days of incubation
of plates at 28◦C. In addition, the strains were tested for
nitrate reduction, tolerance to NaCl, decomposition of citrate,
tartrate, acetate and pyruvate, and pH and temperature tolerance.
The enzymatic activity assays of urease, amylase, protease and
catalase were performed as suggested by Hopwood and Wright
(1973). Finally, on the basis of macroscopic, biochemical and
physiological characteristics hierarchical cluster analysis was
performed by using PASW Statistics (formerly SPSS Statistics)
Version 18 software program and dendrogram was generated
based on the average linkage between the groups.
Metabolite Production
Pure and active cultures of microbial strains selected from the
secondary screening experiments were grown in X-medium (g/l:
Soybean meal, 10; CaCO3, 3; MgSO4.7H2O, 0.5; (NH4)2HPO4,
0.5; NaCl, 3; K2HPO4, 1; glycerol, 15 ml; DW 1, pH 6.9–7.0),
and incubated at 28◦C for 3–5 days and cellular growth was
confirmed by visible pellets, clumps, aggregates or turbidity in the
culture broth. The culture broths were centrifuged separately and
filtrates were used to evaluate the antimicrobial activity against
the above mentioned test microorganisms. Antibiotic activities
of the strains were compared with that of known commercially
available erythromycin (E15) and amphotericin B (AmB100).
Extraction, Purification, and Partial
Characterization of the Active Compounds
Fermented culture was centrifuged at 10,000 rpm for 20 min
to separate the biomass. The active metabolite was recovered
from the fermented broth using two phase solvent extraction
system with organic solvent. Solvents containing the active
compounds were concentrated under vacuum to get “dried
crude.” The obtained “crude” was treated with non-polar solvents
like hexane or chloroform to separate the polar and non-
polar components. The active components were purified by
adsorption chromatography using silica gel (pore size 60 Å,
mesh size: 230–400, particle size 40–63 µm) as a stationary
phase and gel filtration chromatography using sephadex LH-
20. The eluted fractions were assayed for their bioactivity
against B. subtilis ATCC 6633 and C. albicans ATCC 24433
by disc diffusion method (Wu, 1984). The purity of the
active fractions was further checked by high pressure liquid
chromatography (HPLC) using reverse phase silica column
(RP18). Finally, the UV spectra (Perkin Elmer Lambda-25
UV spectrophotometer) of various antibacterial and antifungal
compounds were determined in methanol at 200–500 nm wave
length.
RESULTS
Screening of the Active Strains
During the screening, thirty six actinomycetes were isolated
from six different stressed agro-ecological niches of India.
FIGURE 1 | Primary screening using perpendicular streak method for
antibacterial and antifungal activity of the soil isolate (ZA25).
Microbial colonies showing distinct morphological characters
were selected for the primary screening (Figure 1). Out
of 36 total actinomycetes isolates, 15 showed moderate to
strong antimicrobial activity against gram positive (B. subtilis
MTCC6633, S. aureus MTCC 6538), gram negative (E. coli
MTCC 1304) and fungal strain (C. albicans MTCC 1346). The
active strains (actinomycetes) were further subjected to the
secondary screening against some multi-drug resistant (MDR)
bacterial as well as fungal test strains (Tables 1, 2). The screening
results suggested that most of the isolates were active against
gram positive bacteria in comparison with gram negative bacteria
(Figures 2A,B). Out of 15 active isolates, 13 showed strong
antimicrobial activity and were selected for detailed taxonomic,
physiological, and biochemical studies.
Characterization of the Strains
The cultural characteristics, such as microbial growth along
with its pattern and pigment formation were studied on
International Streptomyces Project (ISP) media and their results
are summarized inTable 3. All the selected actinomycetes isolates
showed moderate to heavy growth on nitrate agar, urease agar
and inorganic salt starch agar medium, which suggests their
capability of breaking down the above complexes. Heavy growth
and color change (from green to blue) of Simmons’ Citrate Agar
(SCA) medium provide the evidence of citrate utilizing ability
of the actinomycetes strains YE21, YE22, and YE23. Likewise,
melanin formation was demonstrated by the presence of brown
to black patches on inorganic salt starch agar (ISP4) and YMG
(yeast extract 4 g, malt extract 10 g, glucose 4 g, agar 20 g, water
1 L) medium as a result of the growth of the active strains. This
was observed in almost all the selected strains.
All the strains were capable of reducing nitrate salts but
they demonstrated some differences against the decomposition
of starch and urea. The production of amylase, urease and
protease enzymes by the actinomycetes strains was endorsed by
their growth on ISP4, urease agar and ISP3 mediums. Except
the actinomycetes strains ZA25, ZA26, and YE22, the most
favorable temperature range for the growth of strains was 27–
37◦C. Interestingly, none of the selected strains were able to grow
at 50◦C or above. All the selected actinomycetes strains possessed
the ability to tolerate 3% NaCl in the medium with the exception
of strains ZE18 and ZA25.
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FIGURE 2 | (A) Secondary screening of the soil isolates for the antibacterial
activities. (B) Secondary screening of the soil isolates for the antifungal
activities.
Hierarchical Cluster Analysis
Strains found to be active in primary and secondary screening
were subjected to hierarchical cluster analysis based on 49
macroscopic, biochemical and physiological characters. The
dendrograms based on the average linkage between the groups
were generated by PASW Statistics (formerly SPSS Statistics)
Version 18 software. Two broad clusters were generated
(Figure 3). The first cluster contained four (ZE18, ZE19, ZA25,
and ZA26) and the second cluster contained nine actinomycetes
(YE23, RS25, H1, V1, N1, S1, YE22, YE21, and K1) isolates. The
first cluster was further divided into two sub cluster sub-clad 1.1
and 1.2. The sub-clad 1.1 leaded ZA25 alone whereas sub-clad
1.2 further divided into 1.2.1 and 1.2.2 and so on, and ultimately
formed a branched group of three isolates (ZE18, ZE19, and
ZA26). Similarly, the second cluster was divided into sub-clad
2.1 and 2.2. The sub-clad 2.1 was further divided into 2.1.1 and
2.1.2 (YE21 and YE2,), whereas sub-clad 2.2 was further divided
into 2.2.1 and 2.2.2 and so on, and ultimately formed a branched
group of seven isolates (YE23, RS25, H1, V1, N1, S1, and K1).
Based upon the potential antimicrobial activities shown in the
primary and secondary screenings, five out of thirteen strains
were finally selected for further characterization using 16S rRNA
homology studies. The generated dendrogram showed that all
the five strains (H1, V1, S1, RS25, and ZA25) were evolutionary
far away from each other and displayed varying biochemical
characteristics along with excellent antimicrobial activity. The
diversity was maintained when we compared the antimicrobial
activity data and the UV spectra of the metabolites. Strains, ZA25
and H1 belong to the main cluster I and II, respectively, found
to produce both antibacterial and antifungal compounds having
different UV absorbance. Similarly, H1, V1, and S1 produce
antibacterial compounds and belong to the same cluster II; but
their sub-clad were different. Variations in the UV absorbance
of the metabolites supported the positional difference of the
strains in the dendrogram. The 16S rRNA study for the strains
H1, V1, and S1 were performed at Microbial Type Culture
Collection (MTCC), Chandigarh, Punjab (India), and identified
and submitted to MTCC as - Streptomyces xanthophaeus MTCC
11938, Streptomyces variabilis MTCC 12266, and Streptomyces
xanthochromogenes MTCC 11937, respectively. Whereas, the
16S rRNA homology sequence study for the strain RS25 and
ZA25 was done at Genomebio Technologies Pvt. Ltd., Pune,
Maharashtra (India) and identified and submitted to National
Collection of Industrial Microorganisms (NCIM), CSIR-NCL,
Pune, Maharashtra (India) as Streptomyces levis EU 124569 and
Streptomyces sp. NCIM 5500, respectively.
Partial Chemical Characterization of the
Active Compounds
The bioactive compounds were purified from the
selected actinomycetes strains using silica column, with
methanol:chloroform gradient as an eluting solvent system. The
purified fractions were partially characterized by observing under
UV absorbance (λmax) and their absorption pattern to gather
some preliminary information regarding the structure of the
compound(s) (Table 4). Absorbance within UV range confirmed
the presence of “unsaturation” in all the bioactive compounds.
All the active metabolites except from the strain RS25 contained
either carboxyl or peptide moiety in their structure. Absorbance
band near 253 nm indicated the presence of benzene moiety in
H1F2 (antifungal; AF), H1F1 (antibacterial; AB) and ZA25 AF
strains. Among antifungal compounds, absence of conjugated
absorption suggested non-polyene nature of H1F1 and ZA25
AF. The presence of carboxyl or peptide moieties was further
confirmed by IR spectra of the compounds. Hydroxyl and
conjugated carbonyl functional moiety in the compound were
confirmed by the presence of absorption bands at 3425 and
1648 cm−1, respectively. The absorption bands detected at 3020
and 2927 cm−1 correspond to aromatic C-H and alkyl C-H
stretching, respectively, and suggested the presence of aromatic
ring in the antibacterial compound isolated from ZA25 and
absence in the compound isolated from V1. Further, presence of
aromatic ring was verified by the absorption bands at 1602 and
1504 cm−1 attributed to C=C ring stretching.
DISCUSSION
During the screening of rare actinomycetes, fast growing
bacterial colonies inhibits the colonization of actinomycetes on
the isolationmedium, hence in order to isolate actinomycetes, the
growth of these bacteria should be inhibited. Pre-treatment of the
soil samples reduced the growth of ubiquitous microbial species,
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TABLE 3 | Cultural and Biochemical characteristics of the producer strains.
Producer strains
Characteristics H1 N1 S1 K1 V1 ZE 18 ZE 19 YE 21 YE 22 YE 23 ZA 25 ZA 26 RS25
Growth on ISP2 2+ + 2+ 2+ 2+ + 2+ 3+ 3+ 2+ 3+ – 3+
ISP3 2+ + 2+ 2+ 2+ 2+ 2+ 2+ 3+ 3+ – 2+ 2+
ISP4 3+ 2+ 2+ 3+ 3+ 2+ 3+ + 2+ 3+ – 3+ 3+
ISP5 2+ 2+ + 2+ + + 2+ + + 2+ – 2+ 2+
ISP6 3+ 2+ 2+ 3+ 2+ + + + 2+ 2+ + + 2+
ISP7 + 2+ + + + + 3+ 2+ 3+ 2+ + – +
Utilization of Citrate – – – + + – – 2+ 2+ 2+ – – –
Asparagine 3+ 2+ + – 2+ – – + + + + – –
Oat meal 2+ + 2+ – 2+ 2+ 2+ 2+ 3+ 3+ – 2+ 2+
Tributyrin 2+ 2+ 2+ 2+ 3+ + – – – + – + +
Enzyme production Urease – – − − − + − 2+ − + − − +
Amylase 3+ 2+ 2+ 2+ 3+ 2+ 3+ + 2+ 3+ − 3+ 3+
Tyrosinase 3+ 2+ − + + + 3+ 2+ 3+ 2+ + − +
Chitinase 3+ 2+ 2+ 2+ + − − 3+ + + − − +
Heparinase − − − − 3+ − − − − − − − −
Protease 2+ 2+ 2+ 2+ 2+ + 2+ 3+ 3+ 2+ 3+ + 3+
Catalase 2+ 2+ 2+ 2+ 2+ + + 2+ 2+ 3+ 2+ + +
pH tolerance 5 3+ 3+ 2+ 3+ 3+ 3+ 3+ 3+ 3+ 2+ 2+ 2+ 3+
7 3+ 2+ 3+ 3+ 3+ + 2+ 3+ 3+ 3+ + + 3+
9 2+ 3+ + 3+ 3+ + + 3+ 3+ 2+ 2+ + 3+
11 − 2+ + 2+ 3+ + + 3+ 3+ 2+ + + 2+
NaCl tolerance 1% 3+ 3+ 3+ 3+ 3+ + 3+ 3+ 3+ 2+ 2+ + 3+
3% + 2+ 2+ 3+ 3+ − + 3+ 3+ 3+ − + +
5% − − + 2+ 2+ − − 3+ 3+ 2+ − − +
7% − − + + + − − + 3+ + − − −
Growth at 28◦C 3+ 2+ 3+ 3+ 2+ + 2+ 3+ + 3+ + + 3+
37◦C 3+ 3+ 2+ 3+ 3+ 2+ 2+ 3+ + 3+ + − 3+
47◦C − − − − + − − − − − − − −
(−), No growth; (+1), Poor growth; (+2), Moderate growth; (+3), Heavy growth.
thereby facilitated the recovery of less-abundantmicroorganisms.
The spores of actinomycetes and fungi generally resist desiccation
and show slightly higher resistance toward wet or dry heat
than other microbes (Hopwood and Wright, 1973). Pre-
treatment of the soil suspension with 1.5% phenol (30◦C
for 30 min) lowered the number of bacteria, fungi, and
other common actinomycetes by denaturing their proteins or
by disrupting their cell membrane, however phenol-resistant
actinomycetes were less affected during this process (Hayakawa
et al., 1991). Earlier, Hayakawa et al. (1991) and Kim et al.
(1995) reported the use of above mentioned pre-treatment
of the soil samples for the isolation of actinomycetes, and
they reported similar results, when the soil samples were pre-
treated.
A total of 15 isolated strains were subjected to antimicrobial
screening and it was found that most of the isolates were active
against gram positive bacteria. This was majorly attributed to
the presence of lipopolysaccharide (LPS), a major structural
unit of gram negative bacterial cell wall. LPS is hydrophobic in
nature and makes the cell wall impermeable to lipophilic solutes,
whereas in absence of LPS in the cell wall of gram positive
bacteria, they become susceptible to the metabolites (Kim et al.,
1994).
Out of 15 strains, thirteen showed strong antimicrobial
activity and were selected for detailed microbial characterization
studies. Melanin formation was also observed in almost all
the selected strains, which is a main diagnostic feature of
Streptomyces sp. (Singh et al., 2009). Further, five strains were
characterized by using nucleotide sequencing and designated
as H1: S. xanthophaeus MTCC 11938, V1: S. variabilis MTCC
12266, S1: S. xanthochromogenes MTCC 11937, RS25: S.
levis EU124569, and ZA 25: Streptomyces sp. NCIM 5500.
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Evolutionary distance of the above five strains (H1, V1, S1, RS25,
and ZA 25) was also analyzed by measuring their positions
in the dendrogram. Based upon the diversity achieved by the
morphological, biochemical, and the phylogenetic characteristics
in the selected strains, we can speculate the possibility of
involvement/role of diverse bioactive compounds from these
strains, responsible for their broad-spectrum antimicrobial
properties.
During the purification of the metabolites from ultra violet
spectra, maximum absorbance between 205 and 216 nm
suggested the presence of carboxyl or peptide moiety in the
structure of all the active metabolites except from the strain RS25
(Singh et al., 2009; Kang et al., 2010). However, absorbance at
240–250 and at 332 nm predicted the presence of chromone like
nucleus in strain RS25 (Griffiths and Ellis, 1972).
FIGURE 3 | Phylogenetic tree showing evolutionary relationship of the
soil isolates.
Pertinent literature about the producer strains were searched
using SciFinder software program and it was found that S.
xanthophaeus is known to produce diverse array of metabolites
including Postproline endopeptidase, Benarthin, β-galactosidase-
inhibiting isoflavonoids and geomycins (Brockmann and Musso,
1954; Hazato et al., 1979; Aoyagi et al., 1992; Shibamoto
et al., 1993). S. xanthochromogenes are also known to produce
diverse array of chemical compounds such as Diastereoisomeric
I-Na, Nitropeptin, xanthicin (I), Pravastatin, reductiomycin,
alkaloid AM-6201 (Arishima et al., 1956; Onda et al., 1982;
Ohba et al., 1987; Otake et al., 1988; Cho et al., 1993; Zhang
et al., 2008). Eleven compounds having same molecular formula
have been reported from S. levis. Those were oleandomycin,
2-piperidinone and derivatives of either erythromycin or
tylonolide. S. variabilis is reported for the production of
L-Glutaminase, imunosuppresive, clavulanic acid, glycoside
antibiotic and 1-hydroxy-1-norresistomycin (Abd-Alla et al.,
2013, 2016; Marques et al., 2014; Ramalingam and Rajaram,
2016).
To the best of our knowledge, this is very first time we are
reporting the antifungal activity of S. xanthophaeus and S.
xanthochromogenes. Similarly, the compounds reported from S.
levis didn’t show the presence of chromone like structure. Also,
the antifungal compound purified from S. xanthochromogenes
was confirmed as chitinase by performing enzyme
assay.
In conclusion, the results of morphological and biochemical
characterization and the nature of compounds produced by
the microbes established the diversity among the member of
actinomycetes. The antimicrobial activities achieved in this
study indicate that the isolated strains of Streptomyces sp.
from different geographical niches of India have potential to
produce diverse array of antimicrobial compounds that can
be useful for many great applications and must be explored
extensively. Currently, our research group and collaborators
are actively involved in the chemical characterization of
the active compounds identified in this study. In addition,
in silico predictive studies for target prediction are under
progress with our collaborator group. Hopefully, in our
successive publication we would be reporting the complete
information regarding the chemical characteristics of the
TABLE 4 | IR spectra of bioactive compounds isolated from the selected actinomycetes strains.
Strains Identification Nature of purified compound UV absorbance IR frequency
H1F1 Streptomyces xanthophaeus Antibacterial 201, 260 3409, 3019, 2400, 1658, 1402, 1384, 1215, 1053, 948,
758, 668
ZA25F1 Streptomyces sp. Antibacterial 264, 495 3411, 3019, 2400, 1647, 1403, 1070, 928, 669
V1 Streptomyces variabilis Antibacterial 210 3412, 2928, 1646, 1215, 1070,
RS25 Streptomyces levis Antibacterial 240-250 and 332 3425 and 1648, 3020 and 2927, 1602 and 1504 cm−1
S1 Streptomyces xanthochromogenes Antifungal 205, 490 3411, 3020, 1646, 1403, 1385, 1216, 1069, 769
H1F2 Streptomyces xanthophaeus Antifungal 201, 265 3850, 3431, 3020, 2399, 2110, 1637, 1403, 1385,
1017, 669
ZA25F2 Streptomyces sp. Antifungal 205, 248, 263, 3850, 3366, 2945, 2833, 2518, 2042, 1638, 1449,
1218, 1113, 757, 666
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“actives” identified in this study and their targets predicted
through in silico binding studies and their experimental
validation.
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